The purpose of the EVI Board as stated in the statutes is:
- To appoint a Scientific Advisory Committee (SAC) from prominent members of the scientific community
- To appoint a Board of Stakeholders
- To set and adjust goals
- To develop scientific policies and strategies based on advice from EVI SAC
- To evaluate progress in relation to objectives and goals
- To approve and when possible to allocate available funding for research and development in accordance with recommendations made by EVI SAC
- To approve the annual work plan of the Secretariat
- To secure funds from European Union (EU) Member States and other interested parties.
The composition of the EVI Board is:
- One representative for each member of EVI-EEIG with a maximum of three representatives per EU Member State, including representatives of pharmaceutical industry.
- The EVI SAC Chair (non-voting member)
- The Chair of the EVI Board of Stakeholders (non-voting member)
The EVI Board meets at least twice a year. Certain decisions require a unanimous vote, such as admission of new members or modification of the statutes. Most other decisions are binding with the support of at least two-thirds of voting members. Routine decisions require only a simple majority.
Decisions regarding funding of proposals are taken on the basis of the text of the proposal, the written summary evaluation prepared by EVI SAC, and a budget estimate prepared by the Secretariat.
The EVI Board is governed by Rules of Procedure.